ID: ALA4864519

Max Phase: Preclinical

Molecular Formula: C27H22FN7O6S3

Molecular Weight: 655.72

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  NS(=O)(=O)c1ccc(Cc2c(-c3cccc(Sc4[nH]nnc4C(=O)O)c3)nn(-c3nc(C(=O)O)cs3)c2CC2CC2)cc1F

Standard InChI:  InChI=1S/C27H22FN7O6S3/c28-18-9-14(6-7-21(18)44(29,40)41)8-17-20(10-13-4-5-13)35(27-30-19(12-42-27)25(36)37)33-22(17)15-2-1-3-16(11-15)43-24-23(26(38)39)31-34-32-24/h1-3,6-7,9,11-13H,4-5,8,10H2,(H,36,37)(H,38,39)(H2,29,40,41)(H,31,32,34)

Standard InChI Key:  HESBKZYQLSNUJF-UHFFFAOYSA-N

Associated Targets(Human)

Hydroxyacid oxidase 1 99 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

L-lactate dehydrogenase A chain 1573 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

L-lactate dehydrogenase A chain 13 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Hydroxyacid oxidase 1 172 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 655.72Molecular Weight (Monoisotopic): 655.0778AlogP: 3.99#Rotatable Bonds: 11
Polar Surface Area: 207.04Molecular Species: ACIDHBA: 11HBD: 4
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 2.74CX Basic pKa: 1.33CX LogP: 5.39CX LogD: -1.17
Aromatic Rings: 5Heavy Atoms: 44QED Weighted: 0.16Np Likeness Score: -1.49

References

1. Ding J, Gumpena R, Boily MO, Caron A, Chong O, Cox JH, Dumais V, Gaudreault S, Graff AH, King A, Knight J, Oballa R, Surendradoss J, Tang T, Wu J, Lowther WT, Powell DA..  (2021)  Dual Glycolate Oxidase/Lactate Dehydrogenase A Inhibitors for Primary Hyperoxaluria.,  12  (7.0): [PMID:34267881] [10.1021/acsmedchemlett.1c00196]

Source